Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-04

FDA Approved: AKLIEF — Original Application (Galderma Laboratories, L.P.)

View source ↗

Summary

FDA approved AKLIEF (trifarotene) by Galderma Laboratories for the treatment of acne vulgaris, including facial and truncal acne.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AKLIEF (trifarotene)

Snippet

ORIG AP for AKLIEF (TRIFAROTENE)